Saluda Medical, Inc. (ASX:SLD)
Australia flag Australia · Delayed Price · Currency is AUD
0.4250
-0.0300 (-6.59%)
Last updated: Sep 2, 2026, 12:01 PM AEST

Saluda Medical Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Revenue
90.1890.1870.3651.6822.23
Revenue Growth
28.17%28.17%36.13%132.45%-
Gross Profit
44.0844.0832.7623.114.04
Operating Income
-148.99-148.99-118.05-99.14-92.22
Net Income
-149.57-149.57-149.3-97.83-92.16
Earnings Per Share
-1.48-1.48-45.92-30.13-28.40
EPS Growth
-----

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023
Period EndingJun '25 Jun '24 Jun '23
United States
49.8832.96.48
Australia
5.297.054.72
Germany
5.364.173.48
Netherlands
3.942.843.49
United Kingdom
32.583.13
Other
2.892.150.94
Total
70.3651.6822.23

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Cash & Investments
118.62118.6254.571.79166.74
Total Debt
99.7599.75205.1271.7967.39
Net Cash (Debt)
18.8718.87-150.620.0199.35
Net Cash Growth
----99.99%-
Net Cash Per Share
0.120.12-46.320.0030.62

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Operating Cash Flow
-115.98-115.98-118.24-93.32-85.66
Capital Expenditures
-0.74-0.74-1.27-1.08-2.37
Free Cash Flow
-116.72-116.72-119.51-94.4-88.03
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Gross Margin
48.89%48.89%46.56%44.72%18.17%
Operating Margin
-165.23%-165.23%-167.79%-191.82%-414.78%
Pretax Margin
-165.09%-165.09%-211.46%-188.76%-411.76%
Profit Margin
-165.87%-165.87%-212.21%-189.29%-414.52%
FCF Margin
-129.44%-129.44%-169.87%-182.66%-395.93%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23
PS Ratio
0.880.89---